Covid vaccine sore throat side effect trial#

Anyone who had a severe allergic reaction after receiving Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 vaccine, should not receive another dose of that vaccine.

Anyone who had a severe allergic reaction after getting an mRNA COVID-19 vaccine (Pfizer-BioNTech or Moderna) should not get another dose of either of the mRNA COVID-19 vaccines.

Covid vaccine sore throat side effect trial#

The experts reportedly also noted that “This vaccine is a whole virus inactivated vaccine, which may better protection, even against mutant strains of the virus, as the immune response will be against multiple antigens and not only against spike protein.”Ī final analysis of phase 3 clinical trial data, which is expected in June, will provide further insight into the vaccine’s efficacy.įor live updates on the latest developments regarding the novel coronavirus and COVID-19, click here.Severe allergic reactions after COVID-19 vaccination are rare. On the other hand, the The New Indian Express has reported that a group of 45 scientists and medical experts signed a statement claiming that the critics’ “irresponsible statements of vested interests” are politically driven and harming the credibility of the research. Two scientific communities, the All India People’s Science Network and the All India Drug Action Network, have criticized the authorization of the vaccine, with the latter citing “intense concerns arising from the absence of the efficacy data.” There have been mixed responses to the speed of Covaxin’s emergency use authorization. MoHFW suggests taking paracetamol, also known as acetaminophen ( Tylenol), to alleviate some of these mild side effects. A similar number of adverse reactions were reported after the second dose. Of the 380 participants who received the first dose of the vaccine, at a concentration of either 3 or 6 micrograms, 17 participants, or 4.5%, experienced injection-related reactions, and 23 participants, or 6.1%, experienced systemic reactions, such as body aches and fever. The vaccine’s phase 1 and 2 clinical trial data state that other reported adverse events include fatigue, body aches, nausea, vomiting, and chills. They are expected to last for a few days. These side effects overlap with those of other currently available COVID-19 vaccines.

pain, swelling, or both at the site of injection.

The virus in an inactivated vaccine triggers an immune response and causes the body to produce antibodies, equipping it to defend itself against potential future infection.Īccording to the Indian government’s Ministry of Health and Family Welfare (MoHFW), the vaccine’s main side effects include: An inactivated vaccine incorporates a modified or dead version of the virus, in this case SARS-CoV-2, which cannot replicate and so cannot cause disease. Beyond India, the vaccine is authorized for emergency use in 12 countries: Bahrain, Botswana, Iran, Mexico, Nepal, the Philippines, Vietnam, Paraguay, Zimbabwe, Guyana, Trinidad and Tobago, and Mauritius.Ĭovaxin, also known as BBV152, is a type of whole-virus vaccine called an inactivated vaccine.

It can now be used to vaccinate people aged 18 and older. India’s drug regulatory authority, the Central Drugs Standard Control Organization, authorized the vaccine for emergency use on January 3, 2021. It is a two-dose vaccine with an efficacy rate of 78%, according to interim phase 3 clinical data. Visit our coronavirus hub for the most recent information on the COVID-19 pandemic.Ĭovaxin is a COVID-19 vaccine developed by Bharat Biotech, an Indian biotechnology company, and the Indian Council of Medical Research.

All data and statistics are based on publicly available data at the time of publication.